01 1Ind Swift Laboratories Limited
01 1LETROZOLE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-05-22
Pay. Date : 2025-05-16
DMF Number : 22093
Submission : 2008-10-08
Status : Active
Type : II
20
Synthimed Labs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.
One of their notable products is LETROZOLE USP, with a corresponding US DMF Number 22093.
Remarkably, this DMF maintains an Active status since its submission on October 08, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 22, 2025, and payment made on May 16, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
